TAS-102, a novel antitumor agent: a review of the mechanism of action

Por Lenz, Heinz-Josef, Stintzing, Sebastian, Loupakis, Fotios
Publicado no Cancer Treat Rev (2015)

Response

Por Cremolini, Chiara, Loupakis, Fotios, Lenz, Heinz-Josef
Publicado no J Natl Cancer Inst (2015)

Beyond KRAS: perspectives on new potential markers of intrinsic and acquired resistance to epidermal growth factor receptor inhibitors in metastatic colorectal cancer

Por Loupakis, Fotios, Cremolini, Chiara, Fontanini, Gabriella, Stasi, Irene, Salvatore, Lisa, Falcone, Alfredo
Publicado em 2009

A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer

Por Loupakis, Fotios, Stein, Alexander, Ychou, Marc, Hermann, Frank, Salud, Antonieta, Österlund, Pia
Publicado no Target Oncol (2015)

BRAF-mutated metastatic colorectal cancer between past and future

Por Cremolini, Chiara, Di Maio, Massimo, Petrelli, Fausto, Berenato, Rosa, Loupakis, Fotios, Pietrantonio, Filippo
Publicado no Br J Cancer (2015)

Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis

Por Basu Roy, Upal K., Henkhaus, Rebecca S., Loupakis, Fotios, Cremolini, Chiara, Gerner, Eugene W., Ignatenko, Natalia A.
Publicado em 2013

Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction

Por Bocci, Guido, Di Paolo, Antonello, Barbara, Cecilia, Masi, Gianluca, Fornaro, Lorenzo, Loupakis, Fotios, Allegrini, Giacomo, Falcone, Alfredo, Del Tacca, Mario, Danesi, Romano
Publicado em 2009

KRAS and BRAF genotyping of synchronous colorectal carcinomas

Por GIANNINI, RICCARDO, LUPI, CRISTIANA, LOUPAKIS, FOTIOS, SERVADIO, ADELE, CREMOLINI, CHIARA, SENSI, ELISA, CHIARUGI, MASSIMO, ANTONIOTTI, CARLOTTA, BASOLO, FULVIO, FALCONE, ALFREDO, FONTANINI, GABRIELLA
Publicado em 2014

Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

Por Loupakis, Fotios, Bria, Emilio, Vaccaro, Vanja, Cuppone, Federica, Milella, Michele, Carlini, Paolo, Cremolini, Chiara, Salvatore, Lisa, Falcone, Alfredo, Muti, Paola, Sperduti, Isabella, Giannarelli, Diana, Cognetti, Francesco
Publicado em 2010

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management

Por Del Prete, Michela, Giampieri, Riccardo, Loupakis, Fotios, Prochilo, Tiziana, Salvatore, Lisa, Faloppi, Luca, Bianconi, Maristella, Bittoni, Alessandro, Aprile, Giuseppe, Zaniboni, Alberto, Falcone, Alfredo, Scartozzi, Mario, Cascinu, Stefano
Publicado no Oncotarget (2015)

Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer

Por Fornaro, Lorenzo, Faviana, Pinuccia, De Gregorio, Veronica, Vivaldi, Caterina, Paolicchi, Elisa, Masi, Gianluca, Loupakis, Fotios, Sensi, Elisa, Lupi, Cristiana, Fontanini, Gabriella, Wang, Yuzhuo, Danesi, Romano, Falcone, Alfredo, Crea, Francesco
Publicado no BMC Cancer (2015)

High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease

Por Ruzzo, Annamaria, Graziano, Francesco, Vincenzi, Bruno, Canestrari, Emanuele, Perrone, Giuseppe, Galluccio, Nadia, Catalano, Vincenzo, Loupakis, Fotios, Rabitti, Carla, Santini, Daniele, Tonini, Giuseppe, Fiorentini, Giammaria, Rossi, David, Falcone, Alfredo, Magnani, Mauro
Publicado em 2012

Influence of Sex on the Survival of Patients With Esophageal Cancer

Por Bohanes, Pierre, Yang, Dongyun, Chhibar, Ruchika S., Labonte, Melissa J., Winder, Thomas, Ning, Yan, Gerger, Armin, Benhaim, Léonor, Paez, David, Wakatsuki, Takeru, Loupakis, Fotios, El-Khoueiry, Rita, Zhang, Wu, Lenz, Heinz-Josef
Publicado em 2012

Prognostic Impact of IL-6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy

Por Matsusaka, Satoshi, Hanna, Diana L., Cao, Shu, Zhang, Wu, Yang, Dongyun, Ning, Yan, Sunakawa, Yu, Okazaki, Satoshi, Berger, Martin D., Miyamato, Yuji, Parekh, Anish, Stintzing, Sebastian, Loupakis, Fotios, Lenz, Heinz-Josef
Publicado no Clin Cancer Res (2016)

Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in sit...

Por Scartozzi, Mario, Bearzi, Italo, Mandolesi, Alessandra, Pierantoni, Chiara, Loupakis, Fotios, Zaniboni, Alberto, Negri, Francesca, Quadri, Antonello, Zorzi, Fausto, Galizia, Eva, Berardi, Rossana, Biscotti, Tommasina, Labianca, Roberto, Masi, Gianluca, Falcone, Alfredo, Cascinu, Stefano
Publicado em 2009

Distinct Gene Expression Profiles of Proximal and Distal Colorectal Cancer: Implications for Cytotoxic and Targeted Therapy

Por Maus, Martin K.H., Hanna, Diana L., Stephens, Craig L., Astrow, Stephanie H., Yang, Dongyun, Grimminger, Peter P., Loupakis, Fotios, Hsiang, Jack H., Zeger, Gary, Wakatsuki, Takeru, Barzi, Afsaneh, Lenz, Heinz-Josef
Publicado no Pharmacogenomics J (2014)

Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer

Por Loupakis, Fotios, Yang, Dongyun, Yau, Linda, Feng, Shibao, Cremolini, Chiara, Zhang, Wu, Maus, Martin K. H., Antoniotti, Carlotta, Langer, Christiane, Scherer, Stefan J., Müller, Thomas, Hurwitz, Herbert I., Saltz, Leonard, Falcone, Alfredo, Lenz, Heinz-Josef
Publicado no J Natl Cancer Inst (2015)

Polymorphisms in genes involved in EGFR-turnover are predictive for cetuximab efficacy in colorectal cancer

Por Stintzing, Sebastian, Zhang, Wu, Heinemann, Volker, Neureiter, Daniel, Kemmerling, Ralf, Kirchner, Thomas, Jung, Andreas, Folwaczny, Matthias, Yang, Dongyun, Ning, Yan, Sebio, Ana, Stremitzer, Stefan, Sunakawa, Yu, Matsusaka, Satoshi, Yamauchi, Shinichi, Loupakis, Fotios, Cremolini, Chiara, Falcone, Alfredo, Lenz, Heinz-Josef
Publicado no Mol Cancer Ther (2015)

Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

Por Loupakis, Fotios, Ruzzo, Annamaria, Salvatore, Lisa, Cremolini, Chiara, Masi, Gianluca, Frumento, Paolo, Schirripa, Marta, Catalano, Vincenzo, Galluccio, Nadia, Canestrari, Emanuele, Vincenzi, Bruno, Santini, Daniele, Bencardino, Katia, Ricci, Vincenzo, Manzoni, Mariangela, Danova, Marco, Tonini, Giuseppe, Magnani, Mauro, Falcone, Alfredo, Graziano, Francesco
Publicado em 2011

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

Por Marmorino, Federica, Salvatore, Lisa, Barbara, Cecilia, Allegrini, Giacomo, Antonuzzo, Lorenzo, Masi, Gianluca, Loupakis, Fotios, Borelli, Beatrice, Chiara, Silvana, Banzi, Maria Chiara, Miraglio, Emanuela, Amoroso, Domenico, Dargenio, Francesco, Bonetti, Andrea, Martignetti, Angelo, Paris, Myriam, Tomcikova, Daniela, Boni, Luca, Falcone, Alfredo, Cremolini, Chiara
Publicado no Br J Cancer (2017)